Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „alafenamide“
Suchtreffer
Begriffe & Kennungen
Descovy · 4.5 · Tenofovir alafenamide: AUC: ↔ Cmax: ↔
Eintrag öffnenDescovy · 4.5 · Tipranavir/ritonavir results in P-gp induction. Tenofovir alafenamide exposure is expected to decrease when ti
Eintrag öffnenDescovy · 4.5 · Tipranavir/ritonavir results in P-gp induction. Tenofovir alafenamide exposure is expected to decrease when ti
Eintrag öffnenDescovy · 4.8 · Patients co-infected with HIV and HBV The safety of emtricitabine and tenofovir alafenamide in combination wit
Eintrag öffnenDescovy · 4.8 · Patients co-infected with HIV and HBV The safety of emtricitabine and tenofovir alafenamide in combination wit
Eintrag öffnenDescovy · 4.8 · Patients with renal impairment The safety of emtricitabine and tenofovir alafenamide was evaluated through 144
Eintrag öffnenDescovy · 4.8 · Patients with renal impairment The safety of emtricitabine and tenofovir alafenamide was evaluated through 144
Eintrag öffnenDescovy · 4.8 · The safety of emtricitabine and tenofovir alafenamide was evaluated through 48 weeks in a single arm, open-lab
Eintrag öffnenDescovy · 4.8 · The safety of emtricitabine and tenofovir alafenamide was evaluated through 48 weeks in a single arm, open-lab
Eintrag öffnenDescovy · 4.8 · The safety of emtricitabine and tenofovir alafenamide was evaluated through 48 weeks in an open- label clinica
Eintrag öffnenDescovy · 4.8 · The safety of emtricitabine and tenofovir alafenamide was evaluated through 48 weeks in an open- label clinica
Eintrag öffnenGenvoya · 4.5 · 7 Tenofovir alafenamide
Eintrag öffnenGenvoya · 4.5 · Cobicistat and tenofovir alafenamide are not inhibitors of human UGT1A1 in vitro. It is not known whether cobi
Eintrag öffnenGenvoya · 4.5 · Genvoya should not be administered concomitantly with medicinal products containing tenofovir alafenamide, ten
Eintrag öffnenGenvoya · 4.5 · Tenofovir alafenamide is transported by P-gp and BCRP. Medicinal products that strongly affect P-gp and BCRP a
Eintrag öffnenGenvoya · 4.5 · Tenofovir alafenamide: AUC: ↔ Cmin: N/A Cmax: ↓ 20%
Eintrag öffnenGenvoya · 4.5 · Tenofovir alafenamide: AUC: ↔ Cmin: N/A Cmax: ↓ 21% Macrolide antibiotics Clarithromycin Interaction not studi
Eintrag öffnenGenvoya · 4.5 · Tenofovir alafenamide: AUC: ↔ Cmin: N/A Cmax: ↔
Eintrag öffnenJuluca · 4.5 · Tenofovir AUC ↑ 23% Cmin ↑ 24% Cmax ↑ 19% Tenofovir alafenamide Dolutegravir No dose adjustment is required.
Eintrag öffnenJuluca · 4.5 · Tenofovir alafenamide / Rilpivirine1 Rilpivirine
Eintrag öffnen